Guidance for industry : use of serological tests to reduce the risk of transmission of trypanosoma cruzi infection in whole blood and blood components for transfusion and human cells, tissues, and cellular and tissue-based products (HCT/Ps).
| Other author/creator | Center for Biologics Evaluation and Research (U.S.) |
| Format | Electronic and Book |
| Publication Info | Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research, [2009] |
| Description | i, 14 p. : digital, PDF file |
| Supplemental Content | https://purl.fdlp.gov/GPO/LPS113497 |
| Subject(s) |
Click here for more information about this title
| Portion of title | Use of serological tests to reduce the risk of transmission of trypanosoma cruzi infection in whole blood and blood components for transfusion and human cells, tissues, and cellular and tissue-based products (HCT/Ps) |
| General note | Title from PDF title page (viewed on June 4, 2009). |
| General note | "Draft guidance". |
| General note | "March 2009". |
| General note | Includes bibliographical references (p. 12-14). |
| General note | GPO Cataloging Record Distribution Program (CRDP). |
| Technical details | Mode of access: Internet at the FDA web site. Address as of 6/4/09: http://www.fda.gov/downloads/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/Tissue/ucm126098.pdf ; current access is available via PURL. |
| GPO item number | 0499-T-02 (online) |
| Govt. docs number | HE 20.4802:SE 6 |
Available Items
| Library | Location | Call Number | Status | Item Actions | |
| Joyner | Electronic Resources | Access Content Online | ✔ Available |